As presented by the expression of CD44/CD24 and tumor sphere formation in MCF-7 and MDA-MB-231, CSNK1G2 also affected the expression of breast stem cell-markers only in ER+ breast cancer cells. This evidence concerns the gene CD44 and neoplasm.